205 related articles for article (PubMed ID: 22290424)
1. Modulation of microRNA processing by mismatch repair protein MutLα.
Mao G; Lee S; Ortega J; Gu L; Li GM
Cell Res; 2012 Jun; 22(6):973-85. PubMed ID: 22290424
[TBL] [Abstract][Full Text] [Related]
2. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
Leong V; Lorenowicz J; Kozij N; Guarné A
Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
[TBL] [Abstract][Full Text] [Related]
3. MutLα heterodimers modify the molecular phenotype of Friedreich ataxia.
Ezzatizadeh V; Sandi C; Sandi M; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
PLoS One; 2014; 9(6):e100523. PubMed ID: 24971578
[TBL] [Abstract][Full Text] [Related]
4. Conservation of functional asymmetry in the mammalian MutLα ATPase.
Johnson JR; Erdeniz N; Nguyen M; Dudley S; Liskay RM
DNA Repair (Amst); 2010 Nov; 9(11):1209-13. PubMed ID: 20864418
[TBL] [Abstract][Full Text] [Related]
5. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Wu X; Platt JL; Cascalho M
Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
[TBL] [Abstract][Full Text] [Related]
6. A CRM1-dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization.
Brieger A; Adam R; Passmann S; Plotz G; Zeuzem S; Trojan J
Genes Chromosomes Cancer; 2011 Feb; 50(2):59-70. PubMed ID: 21064154
[TBL] [Abstract][Full Text] [Related]
7. A novel interaction between human DNA polymerase eta and MutLalpha.
Kanao R; Hanaoka F; Masutani C
Biochem Biophys Res Commun; 2009 Nov; 389(1):40-5. PubMed ID: 19703417
[TBL] [Abstract][Full Text] [Related]
8. Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.
Kosinski J; Hinrichsen I; Bujnicki JM; Friedhoff P; Plotz G
Hum Mutat; 2010 Aug; 31(8):975-82. PubMed ID: 20533529
[TBL] [Abstract][Full Text] [Related]
9. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
[TBL] [Abstract][Full Text] [Related]
10. Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair.
Tomer G; Buermeyer AB; Nguyen MM; Liskay RM
J Biol Chem; 2002 Jun; 277(24):21801-9. PubMed ID: 11897781
[TBL] [Abstract][Full Text] [Related]
11. Saccharomyces cerevisiae MutLalpha is a mismatch repair endonuclease.
Kadyrov FA; Holmes SF; Arana ME; Lukianova OA; O'Donnell M; Kunkel TA; Modrich P
J Biol Chem; 2007 Dec; 282(51):37181-90. PubMed ID: 17951253
[TBL] [Abstract][Full Text] [Related]
12. An intact Pms2 ATPase domain is not essential for male fertility.
Fischer JM; Dudley S; Miller AJ; Liskay RM
DNA Repair (Amst); 2016 Mar; 39():46-51. PubMed ID: 26753533
[TBL] [Abstract][Full Text] [Related]
13. The PMS2 subunit of human MutLalpha contains a metal ion binding domain of the iron-dependent repressor protein family.
Kosinski J; Plotz G; Guarné A; Bujnicki JM; Friedhoff P
J Mol Biol; 2008 Oct; 382(3):610-27. PubMed ID: 18619468
[TBL] [Abstract][Full Text] [Related]
14. DNA mismatch repair and colon cancer.
Marra G; Jiricny J
Adv Exp Med Biol; 2005; 570():85-123. PubMed ID: 18727499
[No Abstract] [Full Text] [Related]
15. Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair.
Plotz G; Welsch C; Giron-Monzon L; Friedhoff P; Albrecht M; Piiper A; Biondi RM; Lengauer T; Zeuzem S; Raedle J
Nucleic Acids Res; 2006; 34(22):6574-86. PubMed ID: 17135187
[TBL] [Abstract][Full Text] [Related]
16. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
17. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.
Peng M; Litman R; Xie J; Sharma S; Brosh RM; Cantor SB
EMBO J; 2007 Jul; 26(13):3238-49. PubMed ID: 17581638
[TBL] [Abstract][Full Text] [Related]
18. Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression.
Clendenning M; Macrae FA; Walsh MD; Walters RJ; Thibodeau SN; Gunawardena SR; Potter JD; Haile RW; Gallinger S; ; Hopper JL; Jenkins MA; Rosty C; Young JP; Buchanan DD
Clin Genet; 2013 Jun; 83(6):591-3. PubMed ID: 23017166
[No Abstract] [Full Text] [Related]
19. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo.
Sansom OJ; Bishop SM; Court H; Dudley S; Liskay RM; Clarke AR
DNA Repair (Amst); 2003 Sep; 2(9):1029-39. PubMed ID: 12967659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]